Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Germ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02596828
What this trial is testing

Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma

Who this might be right for
Pineoblastoma
University of Regensburg 4
Testing effectiveness (Phase 2)Looking for participantsNCT04870944
What this trial is testing

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Who this might be right for
Diffuse Midline Glioma, H3 K27-AlteredMetastatic Malignant Neoplasm in the Central Nervous SystemRecurrent Diffuse Intrinsic Pontine Glioma+7 more
Children's Oncology Group 63
Early research (Phase 1)UnknownNCT04550663
What this trial is testing

NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors

Who this might be right for
Solid TumorHepatocellular CarcinomaColorectal Cancer+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 10
Early research (Phase 1)Study completedNCT02444884
What this trial is testing

MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Excluding CNSNeuroblastoma
Children's Oncology Group 54
Testing effectiveness (Phase 2)Ended earlyNCT01601184
What this trial is testing

Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway

Who this might be right for
Histologically Confirmed MedulloblastomaActivation of the Sonic Hedgehog (SHH) Pathway
Centre Leon Berard 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714
What this trial is testing

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Ended earlyNCT03747484
What this trial is testing

Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

Who this might be right for
Other Skin
Fred Hutchinson Cancer Center 7
Not applicableWithdrawnNCT00980551
What this trial is testing

Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma

Who this might be right for
Retinoblastoma
Children's Hospital Medical Center, Cincinnati
Early research (Phase 1)Active Not RecruitingNCT05222932
What this trial is testing

Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1

Who this might be right for
MelanomaHead and Neck Squamous Cell Carcinoma
TILT Biotherapeutics Ltd. 15
Early research (Phase 1)Ended earlyNCT03416530
What this trial is testing

ONC201 in Pediatric H3 K27M Gliomas

Who this might be right for
Diffuse Intrinsic Pontine GliomaGlioma, Malignant
Jazz Pharmaceuticals 134
Large-scale testing (Phase 3)Study completedNCT01842165
What this trial is testing

177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Jules Bordet Institute 37
Testing effectiveness (Phase 2)Study completedNCT00404495
What this trial is testing

Combination of Irinotecan and Temozolomide in Children With Brain Tumors.

Who this might be right for
GliomaMedulloblastoma
Pfizer 83
Not applicableAvailableNCT01370330
What this trial is testing

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

Who this might be right for
Neuroblastoma
Kieuhoa Vo
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Early research (Phase 1)Ended earlyNCT00990496
What this trial is testing

A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Milton S. Hershey Medical Center 25
Early research (Phase 1)Ended earlyNCT04751383
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT05669430
What this trial is testing

GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Who this might be right for
Solid Tumor, AdultRefractory CancerEndometrial Carcinoma (EC)+4 more
GV20 Therapeutics 365
Testing effectiveness (Phase 2)Study completedNCT03760081
What this trial is testing

Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors

Who this might be right for
Incurable Platinum Refractory Germ Cell TumorsTumors
Astellas Pharma Global Development, Inc. 19
Very early researchUnknownNCT06828341
What this trial is testing

A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression

Who this might be right for
Gliomas
JIANG LONGWEI 3
Early research (Phase 1)Study completedNCT03052205
What this trial is testing

Intratumoral IMO-2125 in Patients With Refractory Solid Tumors

Who this might be right for
Refractory Solid TumorsMelanoma
Idera Pharmaceuticals, Inc. 54
Next Page